Jaguar Health (JAGX) Other Non-Current Assets (2015 - 2026)
Jaguar Health's (JAGX) quarterly Other Non-Current Assets came in at $2.8 million in Q1 2026, up 106.83% year-on-year from $1.3 million in Q1 2025, and up 463.97% on a QoQ basis from $494000.0 in Q4 2025.
Jaguar Health (JAGX) Other Non-Current Assets (2015 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 12 years of Other Non-Current Assets data on file, last reported at $2.8 million in Q1 2026.
- On a quarterly basis, Other Non-Current Assets rose 106.83% year-over-year to $2.8 million in Q1 2026; TTM through Mar 2026 was $2.8 million, a 106.83% increase from a year earlier, with the FY2025 full-year figure at $494000.0, down 63.35% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $2.8 million, up from $494000.0 in the prior quarter.
- Over the last five years, Other Non-Current Assets for JAGX reached as high as $2.8 million in Q1 2026 and fell as low as $275000.0 in Q1 2024.
- Historically, Other Non-Current Assets has averaged $1.1 million across 5 years, with a median of $1.0 million in 2023.
- Across the five-year window, Other Non-Current Assets soared 2247.37% in 2022 and slumped 72.83% in 2024, its largest moves.
- Year by year, Other Non-Current Assets stood at $995000.0 in 2022, then increased by 1.71% to $1.0 million in 2023, then surged by 33.2% to $1.3 million in 2024, then sank by 63.35% to $494000.0 in 2025, then soared by 463.97% to $2.8 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $2.8 million in Q1 2026, $494000.0 in Q4 2025, and $1.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,774.59 Bn | 1,774.53 Bn | - | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | 60,000.00 |
| 3 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn | 104.24 Mn |
| 4 | Vertex Pharmaceuticals | 123.91 Bn | 116.66 Bn | 2.59 Bn | 1.26 Bn |
| 5 | Regeneron Pharmaceuticals | 71.79 Bn | 63.04 Bn | 3.31 Bn | 2.13 Bn |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - | 289.41 Mn |
| 7 | Argenx Se | 54.75 Bn | 49.57 Bn | 1.41 Bn | 124.00 Mn |
| 8 | Alnylam Pharmaceuticals | 38.10 Bn | 35.10 Bn | 959.66 Mn | 63.55 Mn |
| 9 | Revolution Medicines | 36.11 Bn | 36.11 Bn | - | 14.48 Mn |
| 10 | Jaguar Health | 509,443.80 | -9.55 Mn | 19.11 Mn | 2.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.79 Mn |
| Dec 31, 2025 | 494,000.00 |
| Sep 30, 2025 | 1.24 Mn |
| Jun 30, 2025 | 1.24 Mn |
| Mar 31, 2025 | 1.35 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | 276,000.00 |
| Mar 31, 2024 | 275,000.00 |
| Dec 31, 2023 | 1.01 Mn |
| Sep 30, 2023 | 1.01 Mn |
| Jun 30, 2023 | 1.01 Mn |
| Mar 31, 2023 | 1.01 Mn |
| Dec 31, 2022 | 995,000.00 |
| Sep 30, 2022 | 1.84 Mn |
| Jun 30, 2022 | 1.75 Mn |
| Mar 31, 2022 | 446,000.00 |
| Dec 31, 2021 | 446,000.00 |
| Mar 31, 2021 | 19,000.00 |
| Dec 31, 2020 | 37,000.00 |